Sanara MedTech Inc. SMTI
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.04% | 1.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.04% | 1.22% | |||
| Cost of Revenue | 6.24% | 3.00% | |||
| Gross Profit | 0.65% | 1.08% | |||
| SG&A Expenses | 7.30% | 3.29% | |||
| Depreciation & Amortization | -0.99% | 5.41% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.08% | 4.79% | |||
| Operating Income | -58.66% | -32.73% | |||
| Income Before Tax | -213.06% | -203.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -213.06% | -203.37% | |||
| Earnings from Discontinued Operations | -197.84% | -168.47% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -211.66% | -198.67% | |||
| EBIT | -58.66% | -32.73% | |||
| EBITDA | -43.78% | -25.80% | |||
| EPS Basic | -207.27% | -199.24% | |||
| Normalized Basic EPS | -230.41% | -203.50% | |||
| EPS Diluted | -199.45% | -217.09% | |||
| Normalized Diluted EPS | -230.41% | -206.86% | |||
| Average Basic Shares Outstanding | 1.39% | -0.51% | |||
| Average Diluted Shares Outstanding | 1.39% | -3.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||